Trinitrophenol

Trinitrophenol

SCHEMBL253750

O=[N+]([O-])c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1.O=[N+]([O-])c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TRPA1TRPV4

The experimentally established mechanism targets of Trinitrophenol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 11/20 0.79
ALDH1A1 P00352 4/20 0.79
HPGD P15428 2/20 0.79
MAPK1 P28482 2/20 0.79
MEN1 O00255 2/20 0.79
KMT2A Q03164 2/20 0.79
KDM4E B2RXH2 1/20 0.79
TTR P02766 1/20 0.79
CYP1A2 P05177 1/20 0.79
MAPT P10636 1/20 0.79
CYP2C9 P11712 1/20 0.79
ALOX15 P16050 1/20 0.79
ALOX12 P18054 1/20 0.79
RECQL P46063 1/20 0.79
PMP22 Q01453 1/20 0.79
HIF1A Q16665 1/20 0.79
HSD17B10 Q99714 1/20 0.79
TDP1 Q9NUW8 1/20 0.79
TP53 P04637 1/20 0.59
TSHR P16473 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trinitrophenol SCHEMBL8744 1.00 GPR35 (0.79) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL18691159 0.98 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL1692116 0.98 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL9641273 0.98 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL2197458 0.98 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL1503376 0.98 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL2260890 0.98 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL9140811 0.98 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL2218625 0.98 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1
Trinitrophenol SCHEMBL11746249 0.98 GPR35 (0.76) GPR35ALDH1A1HPGDMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113801067-B Benzimidazole derivative and application thereof in detection of nitro aromatic explosives 华南师范大学 2023-02-03 CN disclosed
CN-113801067-A Benzimidazole derivative and application thereof in detection of nitro aromatic explosives 华南师范大学 2021-12-17 CN disclosed
CN-107041947-A Protective effect and application of FSTL1 in anti-fibrosis homeostatic regulation of tissues such as liver 何玉龙 2017-08-15 CN disclosed
US-20120003749-A1 NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO 2,4,6-TRINITROPHENYL SKELETON, METHOD FOR DETECTING COMPOUND HAVING 2,4,6-TRINITROPHENYL SKELETON USING THE NUCLEIC ACID MOLECULE, AND USE OF THE NUCLEIC ACID MOLECULE NEC SOFT, LTD. (JP) 2012-01-05 US disclosed
EP-1577282-B1 Metal complexes for use in olefin metathesis and atom or group transfer reactions TELENE SAS (FR) 2011-06-15 EP disclosed
EP-2298881-A1 NUCLEIC ACID MOLECULE HAVING THE CAPACITY TO BOND WITH A 2,4,6-TRINITROPHENYL STRUCTURE, METHOD FOR DETECTING COMPOUNDS INCLUDING A 2,4,6-TRINITROPHENYL STRUCTURE USING SAID NUCLEIC ACID MOLECULE, AND USE OF SAID NUCLEIC ACID MOLECULE NEC Soft, Ltd. (JP) 2011-03-23 EP disclosed
US-7419636-B2 Vapor sensing instruments for ultra trace chemical detection NOMADICS, INC. (US) 2008-09-02 US disclosed
WO-2007038524-A2 COCRYSTALLIZATION METHODS SSCI, INC. (US) 2007-04-05 WO disclosed
US-20030165407-A1 Vapor sensing instrument for ultra trace chemical detection TELEDYNE FLIR DETECTION, INC. 2003-09-04 US disclosed
US-5210216-A Compounds for sequestering metals such as lead or silver LOCTITE (IRELAND) LIMITED (IE) 1993-05-11 US disclosed
US-5131957-A Improving physical properties of metals by treatment with shock waves BATTELLE MEMORIAL INSTITUTE (US) 1992-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120003749-A1 NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO 2,4,6-TRINITROPHENYL SKELETON, METHOD FOR DETECTING COMPOUND HAVING 2,4,6-TRINITROPHENYL SKELETON USING THE NUCLEIC ACID MOLECULE, AND USE OF THE NUCLEIC ACID MOLECULE NSUN2, TENT4A, DNTT GPR35 3566/4885ALDH1A1 3909/4885HPGD 4067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.